{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:09:54Z","timestamp":1790507394491,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","award":["2019S008"],"award-info":[{"award-number":["2019S008"]}],"id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Potentially Inappropriate Medications (PIMs) and polypharmacy are widely used indicators of suboptimal prescribing for older people. The aim of this study was to describe the changes in the prevalence of PIMs and polypharmacy among people aged 75\u2009years and over between 2011 and 2019 in France.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PIMs and polypharmacy were assessed among people aged 75\u2009years and over every two years between 2011 and 2019 using the French health insurance data system. Sixteen PIM criteria from the 2015 Beers and STOPP lists were assessed. Polypharmacy (5 to 9 drugs) and hyper-polypharmacy (\u226510 drugs) were defined based on the average number of drugs dispensed per quarter. The Annual Percent Change (APC) and 95%CI were assessed using linear regression models after standardization of the prevalence on age and sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study population included 5,777,645 individuals over 75\u2009years old in 2011 and 6,328,155 in 2019. The prevalence of PIMs decreased from 49.6 to 39.6% over the study period (APC: \u2212\u20091.19% [\u2212\u20091.35;-1.04]). Of the sixteen indicators assessed, the prevalence of thirteen decreased between 2011 and 2019. Benzodiazepines were the most frequent PIMs (34.7% in 2011 to 26.9% in 2019), followed by anticholinergic drugs (12.1% in 2011 to 8.3% in 2019), oral non-steroidal anti-inflammatory drugs (11.4 to 7.8%), and PIMs related to antihypertensive drugs (7.4 to 6.0%). Overall, women and individuals aged 85\u2009years and older were more likely to receive PIMs. The prevalence of hyper-polypharmacy decreased from 30.5 to 25.9% over the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study, which is the first to assess the change in prevalence of PIMs and polypharmacy over time from comprehensive health data in France, highlights that PIMs and hyper-polypharmacy declined between 2011 and 2019. However, PIMs remains frequent for older people and often involves benzodiazepines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-021-02568-1","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T09:02:59Z","timestamp":1635843779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Decreasing trends in potentially inappropriate medications in older people: a nationwide repeated cross-sectional study"],"prefix":"10.1186","volume":"21","author":[{"given":"Sol\u00e8ne","family":"Drusch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thien","family":"Le Tri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Ankri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Zureik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Herr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"key":"2568_CR1","volume-title":"Ageing Europe: looking at the lives of older people in the EU\u00a0: 2020 edition","author":"L Corselli-Nordblad","year":"2020","unstructured":"Corselli-Nordblad L, Strandell H. European Commission, Statistical Office of the European Union. In: Ageing Europe: looking at the lives of older people in the EU\u00a0: 2020 edition; 2020."},{"key":"2568_CR2","doi-asserted-by":"publisher","unstructured":"Aggarwal P, Woolford SJ, Patel HP. Multi-morbidity and polypharmacy in older people: challenges and opportunities for clinical practice. Geriatr Basel Switz. 2020;5. https:\/\/doi.org\/10.3390\/geriatrics5040085.","DOI":"10.3390\/geriatrics5040085"},{"key":"2568_CR3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s40471-019-00214-4","volume":"6","author":"C Sirois","year":"2019","unstructured":"Sirois C, Simard M, Gosselin E, Gagnon M-E, Roux B, Laroche M-L. Mixed bag \u201cpolypharmacy\u201d: methodological pitfalls and challenges of this exposure definition. Curr Epidemiol Rep. 2019;6:390\u2013401. https:\/\/doi.org\/10.1007\/s40471-019-00214-4.","journal-title":"Curr Epidemiol Rep"},{"key":"2568_CR4","doi-asserted-by":"publisher","unstructured":"Guillot J, Maumus-Robert S, Bezin J. Polypharmacy: a general review of definitions, descriptions and determinants. Therapie. 2019. https:\/\/doi.org\/10.1016\/j.therap.2019.10.001.","DOI":"10.1016\/j.therap.2019.10.001"},{"key":"2568_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","volume":"21","author":"LE Davies","year":"2020","unstructured":"Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse outcomes of polypharmacy in older people: systematic review of reviews. J Am Med Dir Assoc. 2020;21:181\u20137. https:\/\/doi.org\/10.1016\/j.jamda.2019.10.022.","journal-title":"J Am Med Dir Assoc"},{"key":"2568_CR6","doi-asserted-by":"publisher","first-page":"f7033","DOI":"10.1136\/bmj.f7033","volume":"347","author":"J Wise","year":"2013","unstructured":"Wise J. Polypharmacy: a necessary evil. BMJ. 2013;347:f7033. https:\/\/doi.org\/10.1136\/bmj.f7033.","journal-title":"BMJ"},{"key":"2568_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1124\/pr.56.2.4","volume":"56","author":"AJ McLean","year":"2004","unstructured":"McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56:163\u201384. https:\/\/doi.org\/10.1124\/pr.56.2.4.","journal-title":"Pharmacol Rev"},{"key":"2568_CR8","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","unstructured":"By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63:2227\u201346. https:\/\/doi.org\/10.1111\/jgs.13702.","journal-title":"J Am Geriatr Soc"},{"key":"2568_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213\u20138. https:\/\/doi.org\/10.1093\/ageing\/afu145.","journal-title":"Age Ageing"},{"key":"2568_CR10","doi-asserted-by":"publisher","unstructured":"Liew TM, Lee CS, Goh SKL, Chang ZY. The prevalence and impact of potentially inappropriate prescribing among older persons in primary care settings: multilevel meta-analysis. Age Ageing. 2020. https:\/\/doi.org\/10.1093\/ageing\/afaa057.","DOI":"10.1093\/ageing\/afaa057"},{"key":"2568_CR11","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/14740338.2018.1546841","volume":"17","author":"JW Wastesson","year":"2018","unstructured":"Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17:1185\u201396. https:\/\/doi.org\/10.1080\/14740338.2018.1546841.","journal-title":"Expert Opin Drug Saf"},{"key":"2568_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12877-015-0143-8","volume":"15","author":"A Ble","year":"2015","unstructured":"Ble A, Masoli JAH, Barry HE, Winder RE, Tavakoly B, Henley WE, et al. Any versus long-term prescribing of high risk medications in older people using 2012 Beers criteria: results from three cross-sectional samples of primary care records for 2003\/4, 2007\/8 and 2011\/12. BMC Geriatr. 2015;15:146. https:\/\/doi.org\/10.1186\/s12877-015-0143-8.","journal-title":"BMC Geriatr"},{"key":"2568_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008656","volume":"5","author":"F Moriarty","year":"2015","unstructured":"Moriarty F, Hardy C, Bennett K, Smith SM, Fahey T. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open. 2015;5:e008656. https:\/\/doi.org\/10.1136\/bmjopen-2015-008656.","journal-title":"BMJ Open"},{"key":"2568_CR14","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00228-018-2534-1","volume":"74","author":"DC Muhlack","year":"2018","unstructured":"Muhlack DC, Hoppe LK, Stock C, Haefeli WE, Brenner H, Sch\u00f6ttker B. The associations of geriatric syndromes and other patient characteristics with the current and future use of potentially inappropriate medications in a large cohort study. Eur J Clin Pharmacol. 2018;74:1633\u201344. https:\/\/doi.org\/10.1007\/s00228-018-2534-1.","journal-title":"Eur J Clin Pharmacol"},{"key":"2568_CR15","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/ageing\/afw243","volume":"46","author":"L Bruin-Huisman","year":"2017","unstructured":"Bruin-Huisman L, Abu-Hanna A, van Weert HCPM, Beers E. Potentially inappropriate prescribing to older patients in primary care in the Netherlands: a retrospective longitudinal study. Age Ageing. 2017;46:614\u20139. https:\/\/doi.org\/10.1093\/ageing\/afw243.","journal-title":"Age Ageing"},{"key":"2568_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s40266-014-0165-5","volume":"31","author":"B Hovstadius","year":"2014","unstructured":"Hovstadius B, Petersson G, Hellstr\u00f6m L, Ericson L. Trends in inappropriate drug therapy prescription in the elderly in Sweden from 2006 to 2013: assessment using national indicators. Drugs Aging. 2014;31:379\u201386. https:\/\/doi.org\/10.1007\/s40266-014-0165-5.","journal-title":"Drugs Aging"},{"key":"2568_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/jgs.13320","volume":"63","author":"AJ Davidoff","year":"2015","unstructured":"Davidoff AJ, Miller GE, Sarpong EM, Yang E, Brandt N, Fick DM. Prevalence of potentially inappropriate medication use in older adults using the 2012 Beers criteria. J Am Geriatr Soc. 2015;63:486\u2013500. https:\/\/doi.org\/10.1111\/jgs.13320.","journal-title":"J Am Geriatr Soc"},{"key":"2568_CR18","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/pds.1762","volume":"18","author":"B Bongue","year":"2009","unstructured":"Bongue B, Naudin F, Laroche M-L, Galteau M-M, Guy C, Gu\u00e9guen R, et al. Trends of the potentially inappropriate medication consumption over 10 years in older adults in the east of France. Pharmacoepidemiol Drug Saf. 2009;18:1125\u201333. https:\/\/doi.org\/10.1002\/pds.1762.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2568_CR19","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00228-011-1077-5","volume":"67","author":"B Bongue","year":"2011","unstructured":"Bongue B, Laroche ML, Gutton S, Colvez A, Gu\u00e9guen R, Moulin JJ, et al. Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system. Eur J Clin Pharmacol. 2011;67:1291\u20139. https:\/\/doi.org\/10.1007\/s00228-011-1077-5.","journal-title":"Eur J Clin Pharmacol"},{"key":"2568_CR20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/ageing\/afw245","volume":"46","author":"J-B Beuscart","year":"2017","unstructured":"Beuscart J-B, Genin M, Dupont C, Verloop D, Duhamel A, Defebvre M-M, et al. Potentially inappropriate medication prescribing is associated with socioeconomic factors: a spatial analysis in the French Nord-Pas-de-Calais region. Age Ageing. 2017;46:607\u201313. https:\/\/doi.org\/10.1093\/ageing\/afw245.","journal-title":"Age Ageing"},{"key":"2568_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.120.16314","volume":"77","author":"S Laura","year":"2021","unstructured":"Laura S, J\u00e9r\u00e9mie B, J\u00e9r\u00f4me D, B\u00e9rang\u00e8re B, Cl\u00e9mentine V, Fran\u00e7ois C, et al. Antihypertensive drugs and COVID-19 risk. Hypertension. 2021;77:833\u201342. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.16314.","journal-title":"Hypertension"},{"key":"2568_CR22","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/pds.4233","volume":"26","author":"J Bezin","year":"2017","unstructured":"Bezin J, Duong M, Lassalle R, Droz C, Pariente A, Blin P, et al. The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2017;26:954\u201362. https:\/\/doi.org\/10.1002\/pds.4233.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2568_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/pds.966","volume":"14","author":"BG Fincke","year":"2005","unstructured":"Fincke BG, Snyder K, Cantillon C, Gaehde S, Standring P, Fiore L, et al. Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Saf. 2005;14:121\u20138. https:\/\/doi.org\/10.1002\/pds.966.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2568_CR24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","unstructured":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67:674\u201394. https:\/\/doi.org\/10.1111\/jgs.15767.","journal-title":"J Am Geriatr Soc"},{"key":"2568_CR25","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/sim.3733","volume":"28","author":"LX Clegg","year":"2009","unstructured":"Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28:3670\u201382 https:\/\/doi.org\/10.1002\/sim.3733.","journal-title":"Stat Med"},{"key":"2568_CR26","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jamda.2016.06.011","volume":"17","author":"L Morin","year":"2016","unstructured":"Morin L, Laroche M-L, Texier G, Johnell K. Prevalence of Potentially Inappropriate Medication Use in Older Adults Living in Nursing Homes: A Systematic Review. J Am Med Dir Assoc. 2016;17:862.e1\u20139. https:\/\/doi.org\/10.1016\/j.jamda.2016.06.011.","journal-title":"J Am Med Dir Assoc"},{"key":"2568_CR27","unstructured":"Benard A, Billioti de Gage S, Canarelli T, Cavali\u00e9 P, Chatila K, Collin C, et al. \u00c9tat des Lieux de la Consommation des Benzodiaz\u00e9pines en France, 2017. [Internet]. French National Agency for the Safety of Medicines and Health Products; 2017. [cited 2021 Oct 25]. Available from: https:\/\/archiveansm.integra.fr\/S-informer\/Points-d-information-Points-d-information\/Etat-des-lieux-de-la-consommation-des-benzodiazepines-Point-d-Information."},{"key":"2568_CR28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.yfrne.2014.05.004","volume":"35","author":"M Altemus","year":"2014","unstructured":"Altemus M, Sarvaiya N, Epperson CN. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol. 2014;35:320\u201330. https:\/\/doi.org\/10.1016\/j.yfrne.2014.05.004.","journal-title":"Front Neuroendocrinol"},{"key":"2568_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12875-016-0440-0","volume":"17","author":"AE Thompson","year":"2016","unstructured":"Thompson AE, Anisimowicz Y, Miedema B, Hogg W, Wodchis WP, Aubrey-Bassler K. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract. 2016;17:38. https:\/\/doi.org\/10.1186\/s12875-016-0440-0.","journal-title":"BMC Fam Pract"},{"key":"2568_CR30","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00228-013-1499-3","volume":"69","author":"CE Dur\u00e1n","year":"2013","unstructured":"Dur\u00e1n CE, Azermai M, Vander Stichele RH. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol. 2013;69:1485\u201396. https:\/\/doi.org\/10.1007\/s00228-013-1499-3.","journal-title":"Eur J Clin Pharmacol"},{"key":"2568_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12877-020-1476-5","volume":"20","author":"K Thorell","year":"2020","unstructured":"Thorell K, Midl\u00f6v P, Fastbom J, Halling A. Use of potentially inappropriate medication and polypharmacy in older adults: a repeated cross-sectional study. BMC Geriatr. 2020;20:73. https:\/\/doi.org\/10.1186\/s12877-020-1476-5.","journal-title":"BMC Geriatr"},{"key":"2568_CR32","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/gerona\/glv013","volume":"70","author":"CJ Charlesworth","year":"2015","unstructured":"Charlesworth CJ, Smit E, Lee DSH, Alramadhan F, Odden MC. Polypharmacy among adults aged 65 years and older in the United States: 1988-2010. J Gerontol A Biol Sci Med Sci. 2015;70:989\u201395. https:\/\/doi.org\/10.1093\/gerona\/glv013.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2568_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212046","volume":"14","author":"M van den Akker","year":"2019","unstructured":"van den Akker M, Vaes B, Goderis G, Van Pottelbergh G, De Burghgraeve T, Henrard S. Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015. PLoS One. 2019;14:e0212046. https:\/\/doi.org\/10.1371\/journal.pone.0212046.","journal-title":"PLoS One"},{"key":"2568_CR34","unstructured":"Les d\u00e9penses de sant\u00e9 en 2018. R\u00e9sultats des comptes de la sant\u00e9. [Internet]. Direction de la recherche, des \u00e9tudes de l\u2019\u00e9valuation et des statistiques; 2019. [cited 2021 Oct 25]. Available from: https:\/\/drees.solidarites-sante.gouv.fr\/publications\/panoramas-de-la-drees\/les-depenses-de-sante-en-2018-resultats-des-comptes-de-la-sante."}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-021-02568-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-021-02568-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-021-02568-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T09:05:31Z","timestamp":1635843931000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-021-02568-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2568"],"URL":"https:\/\/doi.org\/10.1186\/s12877-021-02568-1","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,2]]},"assertion":[{"value":"13 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been authorized and realized according to the decree 2016\u20131871 from the 26th of December 2016 relating to the processing of personal data called \u201cNational Health Data System\u201d and French law articles Art. R. 1461\u20131323 and 1424(5). As permanent user of SNDS, the author\u2019s team is exempted from Institutional Review Board approval. Given that data are anonymous, no informed consents to participate is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interests\/competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"621"}}